StockData
Cencora, Inc. logo

Cencora, Inc.

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 15/3019% above fair value
$339.09−2.16 (-0.63%)

Close on Nov 20, 2026Market cap $64.71BP/E 25.2Yield 0.65%

Cencora Peer Benchmark: Cardinal Health, Inc. (CAH) by Quarter

Peer Benchmark: Cardinal Health, Inc. (CAH) — Consolidated Revenue ($M) ($M)

Periods

Cencora Peer Benchmark: Cardinal Health, Inc. (CAH): $65,627M in Q1 FY26, up 18.8% from a year earlier. That is the highest of the 64 quarters on record here.

Latest, Q1 FY26
65,627
Period ended Dec 31, 2025 (CQ4 2025)
Change on a year earlier
+18.8%
55,264 in Q1 FY25
History
64 quarters
Since Q4 FY08
Sources
1
SEC EDGAR XBRL CompanyFacts (CAH)

Where the Q1 FY26 figure comes from

“CAH us-gaap:Revenues = $65,627,000,000 (2025-10-01 to 2025-12-31)”

Source: SEC EDGAR XBRL CompanyFacts (CAH) ↗

SEC XBRL quarterly and annual financial benchmark for Big-3 pharmaceutical distribution peer Cardinal Health, Inc. (CIK 0000721371, aligned to Cencora's fiscal calendar).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPeer Benchmark: Cardinal Health, Inc. (CAH) — Consolidated Revenue ($M) ($M)Year on yearSource
Q1 FY26CQ4 2025Dec 31, 202565,627+18.8%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q4 FY25CQ3 2025Sep 30, 202564,009+22.4%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q2 FY25CQ1 2025Mar 31, 202554,8780.0%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q1 FY25CQ4 2024Dec 31, 202455,264-3.8%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q4 FY24CQ3 2024Sep 30, 202452,277-4.3%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q2 FY24CQ1 2024Mar 31, 202454,868+8.7%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q1 FY24CQ4 2023Dec 31, 202357,442+11.6%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q4 FY23CQ3 2023Sep 30, 202354,650+10.2%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q2 FY23CQ1 2023Mar 31, 202350,498+12.6%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q1 FY23CQ4 2022Dec 31, 202251,468+13.2%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q4 FY22CQ3 2022Sep 30, 202249,592+12.8%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q2 FY22CQ1 2022Mar 31, 202244,836+14.2%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q1 FY22CQ4 2021Dec 31, 202145,457+9.4%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q4 FY21CQ3 2021Sep 30, 202143,968+12.6%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q2 FY21CQ1 2021Mar 31, 202139,275+0.3%SEC EDGAR XBRL CompanyFacts (CAH) ↗
Q1 FY21CQ4 2020Dec 31, 202041,541+4.5%SEC EDGAR XBRL CompanyFacts (CAH) ↗

Breakdown

What makes up peer Benchmark: Cardinal Health, Inc. (CAH)

Cite this data

StockData. (2026). Cencora Peer Benchmark: Cardinal Health, Inc. (CAH) ($M), quarterly Q4 FY08–Q1 FY26 [Data set]. Compiled from Cencora SEC filings and investor materials. https://stockdatahq.com/stocks/cor/kpis/peer-cah-rev

See every metric in the Cencora KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?